|
Class 2 Device Recall |
|
Date Initiated by Firm |
June 11, 2004 |
Date Posted |
October 23, 2004 |
Recall Status1 |
Terminated 3 on June 07, 2005 |
Recall Number |
Z-0043-05 |
Recall Event ID |
30026 |
Product Classification |
System, Multipurpose For In Vitro Coagulation Studies - Product Code JPA
|
Product |
The MDA¿ system with MDA¿ Antithrombin III MDA¿ Heparin
|
Code Information |
All product numbers |
Recalling Firm/ Manufacturer |
bioMerieux 100 Rodolphe St Bldg 1300 Durham NC 27712-9402
|
For Additional Information Contact |
Jocelyn Jennings 919-620-2968
|
Manufacturer Reason for Recall |
The firm received complaints regarding an observed bias in percent activity between capped and uncapped specimens.
|
FDA Determined Cause 2 |
Other |
Action |
Consignees were initially notified by letter on June 11, 2004. A follow up letter was sent to consignees, via Fedex on July 9, 2004. |
Distribution |
Nationwide, Australia, Belgium, Brazil, Canada, China, Germany, Italy, Japan, Taiwan, UK |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|